The proposed mechanism was verified by the results of in vivo experiments, which showed that ECT2 reduced the effect of decreased infiltration of M2 macrophages, promoted the apoptosis of tumor cells, and increased the activity of NK cells in the tumor microenvironment. Here, ECT2 is linked to neoplasm.